Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. - Wikidata - wikimedia - TriplyDB

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.

http://www.wikidata.org/entity/Q35542959

about

Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.Improving the safety of cell therapy with the TK-suicide gene The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.Hematopoietic stem cell transplantation and cellular therapy.Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia.Immunotherapy for acute leukemia.Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia.Cord blood chimerism and relapse after haplo-cord transplantation.The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.Against the odds: haplo-cord grafts protect from GvHD and relapse.HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

P2860

Q26771438-FB92223E-D770-4BD2-BD3F-464F8F269D98 Q30252205-9FA200EE-EAE6-46C4-9054-C54C534B6EE7 Q34477411-ABAA4871-CC93-4171-9CA2-9209971C252C Q36055223-20DE75BC-A1B2-49CD-9088-46C9D48B2E75 Q36928803-C81D709C-E932-4A82-95C8-B578468A2B8D Q37015691-791CF2DE-1F45-4DA0-8852-2447D43A726E Q37216236-CA911BCC-6858-4617-8F8E-F114FF085DC1 Q38798545-DEB8D312-0F1B-42CC-90C1-2D0FE1B68221 Q39216720-CCCAD231-EC81-4BBF-9B5C-395AADF77A41 Q40038510-4C68F517-C3DA-4D8E-8DD0-F5B10A713A6E Q40843011-5B0FC6D5-5ECA-465C-AFD2-E299D71AAA6D Q42348816-29103236-5298-4C4F-A53D-A18526C03BF6 Q48505253-7F544604-1632-4139-A851-EA8858CE1AA4 Q50417473-DC81597F-49F6-499F-A591-E4A5DC16C419 Q52971841-E0EED0FE-653B-480C-BDD0-4DB60B6BE011 Q53082542-39AD3E57-CE1E-4FBE-923C-D9137FB674C0 Q53211922-DFA7CC45-9903-411A-812E-748DA3727A58 Q53491938-6D871D96-EC10-4B8F-9175-1DE12D5A126F Q55240175-BD69F930-B04F-47CE-8FAA-D719A8F7C963 Q57821741-89E3E847-2B32-4E6E-8BC3-261BD706BF7C

P2860

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.

http://www.wikidata.org/entity/Q35542959

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@ast

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@en

type

label

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@ast

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@en

prefLabel

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@ast

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@en

P1433

Q35542959-C8EE956B-3E6C-411F-BA33-5A187A98DC09

P1476

Q35542959-08B50CA0-AE50-4F19-A19C-DF4DFFCC6F67

P2093

Q35542959-0419130B-EA1B-4F71-B2C0-1D78C3F453BD

Q35542959-0FF17A45-7C44-4136-A9CB-8C7F8C762EC8

Q35542959-1BA9487C-740D-4BE4-9D27-C5920CE0F560

Q35542959-35CBCEC3-9999-445A-BF87-2399994463E4

Q35542959-3F9128E2-734C-40DC-9E18-C6ADE69C0D2D

Q35542959-4AAA0328-BBE6-44FB-9CC7-CD898899BE28

Q35542959-4FC4F12B-E866-460F-AC40-50D0084F6289

Q35542959-56707162-A10B-4652-A779-5E675BB76E9E

Q35542959-58DA9C58-2B22-4524-BA52-1C75D1CEC82C

Q35542959-6533B486-929D-4B4E-B5FE-1206F24E1464

P2860

Q35542959-05AD004C-DD96-4B8C-9274-5D29601EB50E

Q35542959-161D7199-0E56-4B5E-B474-50574DEDC002

Q35542959-1E7A8AF6-88C1-4DC1-BAA6-0CA6139EC592

Q35542959-204E357A-654C-4D4C-A431-DCB0FB2781A0

Q35542959-44032536-29B5-4FE3-97A1-5C5AE4DC8F44

Q35542959-57671984-791C-47DA-B4C6-973F0613DD5D

Q35542959-576BCDEB-FFEE-4598-94A2-B9599B9BE641

Q35542959-71138B9D-E2EF-46BF-8CE0-8E19B7F1D869

Q35542959-73B442DE-EAC2-41EC-A2FD-6EFE7EEE2F13

Q35542959-7B22F776-6B3C-4372-86F9-74DF2338F7D3

P304

Q35542959-73E230F0-A2B9-4AA1-8F4A-EADC63B02F4D

P31

Q35542959-65A737A1-0480-401E-9166-BD244C7B1E5C

P356

Q35542959-2D1E0284-559B-489E-A5FE-B12E2F0FA7BB

P407

Q35542959-6A8DDF6F-4787-44C2-AE2F-34A66A177E26

P433

Q35542959-2EC0A0C0-923D-4485-81B5-45DD6B127039

P478

Q35542959-34B4444B-BAAD-4243-9016-2CBE38C88D27

P50

Q35542959-2E3BAEC4-C34C-4B71-99A1-DC699F84D813

P577

Q35542959-A5081370-B58F-432B-BD24-C7E7DEC0E4C2

P698

Q35542959-BCAA9699-A6E2-4BE2-83A4-963897434BAA

P932

Q35542959-1952E7FC-C524-4BB4-9EC3-BD1F905AEFED

P356

1078-0432.CCR-14-0586

P1433

Clinical Cancer Research

P1476

Impact of Chronic Graft-versus ...... Transplantation for Leukemia.

@en

P2093

Alvaro Urbano-Ispizua

http://www.w3.org/2001/XMLSchema#string

Anna Hassebroek

http://www.w3.org/2001/XMLSchema#string

Brian J Bolwell

http://www.w3.org/2001/XMLSchema#string

Corey S Cutler

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

David A Jacobsohn

http://www.w3.org/2001/XMLSchema#string

Effie W Petersdorf

http://www.w3.org/2001/XMLSchema#string

Harry C Schouten

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Y Cahn

http://www.w3.org/2001/XMLSchema#string

John P Klein

http://www.w3.org/2001/XMLSchema#string

P2860

The EBMT activity survey: 1990-2010

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

P304

2020-2028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-0586

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Robert Peter Gale

P577

2014-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25348512

http://www.w3.org/2001/XMLSchema#string

P932

4411210

http://www.w3.org/2001/XMLSchema#string